Search research articles
Contact Us
Filters
Showing results (261-270 of 611) with videos related to
Page
of 62
Sort By:
Neurology
|
July 1, 1984
Pergolide in the treatment of Parkinson's disease
J Y Mear, G Barroche, Y de Smet, et al.
Brain Research
|
March 11, 1982
Microtopography of methionine-enkephalin, dopamine and noradrenaline in the ventral mesencephalon of human control and Parkinsonian brains
H Taquet, F Javoy-Agid, F Cesselin, et al.
Neuroscience Letters
|
October 27, 1995
Striatal expression of substance P and methionin-enkephalin in genes in patients with Parkinson's disease
R Levy, M Vila, M T Herrero, et al.
Journal of Medical Genetics
|
November 1, 1992
Duplication within chromosome 17p11.2 in 12 families of French ancestry with Charcot-Marie-Tooth disease type 1a. The French CMT Research Group
A Brice, N Ravisé, G Stevanin, et al.
Neuroscience Letters
|
November 21, 1994
Loss of striatal high affinity NGF binding sites in progressive supranuclear palsy but not in Parkinson's disease
J Villares, O Strada, B Faucheux, et al.
Brain Research
|
June 23, 1987
Regional distribution of mu, delta and kappa opioid receptors in human brains from controls and parkinsonian subjects
P Delay-Goyet, J M Zajac, F Javoy-Agid, et al.
Neuroscience Letters
|
May 19, 1994
Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's disease
G Boka, P Anglade, D Wallach, et al.
Brain Research
|
August 26, 1985
Dynorphin levels in parkinsonian patients: Leu5-enkephalin production from either proenkephalin A or prodynorphin in human brain
H Taquet, F Javoy-Agid, P Giraud, et al.
Revue Neurologique
|
January 1, 1985
[Dementia and Parkinson's disease: biochemical and anatomo-clinical correlation]
B Dubois, J J Hauw, M Ruberg, et al.
Brain Research
|
October 8, 1993
Differential vulnerability to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine of dopaminergic and cholinergic neurons in the monkey mesopontine tegmentum
M T Herrero, E C Hirsch, F Javoy-Agid, et al.
Page
of 62
Search research articles
Search
Showing results (261-270 of 611) with videos related to
Sort By:
Page
of 62
Neurology
|
July 1, 1984
Pergolide in the treatment of Parkinson's disease
J Y Mear, G Barroche, Y de Smet, et al.
Brain Research
|
March 11, 1982
Microtopography of methionine-enkephalin, dopamine and noradrenaline in the ventral mesencephalon of human control and Parkinsonian brains
H Taquet, F Javoy-Agid, F Cesselin, et al.
Neuroscience Letters
|
October 27, 1995
Striatal expression of substance P and methionin-enkephalin in genes in patients with Parkinson's disease
R Levy, M Vila, M T Herrero, et al.
Journal of Medical Genetics
|
November 1, 1992
Duplication within chromosome 17p11.2 in 12 families of French ancestry with Charcot-Marie-Tooth disease type 1a. The French CMT Research Group
A Brice, N Ravisé, G Stevanin, et al.
Neuroscience Letters
|
November 21, 1994
Loss of striatal high affinity NGF binding sites in progressive supranuclear palsy but not in Parkinson's disease
J Villares, O Strada, B Faucheux, et al.
Brain Research
|
June 23, 1987
Regional distribution of mu, delta and kappa opioid receptors in human brains from controls and parkinsonian subjects
P Delay-Goyet, J M Zajac, F Javoy-Agid, et al.
Neuroscience Letters
|
May 19, 1994
Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's disease
G Boka, P Anglade, D Wallach, et al.
Brain Research
|
August 26, 1985
Dynorphin levels in parkinsonian patients: Leu5-enkephalin production from either proenkephalin A or prodynorphin in human brain
H Taquet, F Javoy-Agid, P Giraud, et al.
Revue Neurologique
|
January 1, 1985
[Dementia and Parkinson's disease: biochemical and anatomo-clinical correlation]
B Dubois, J J Hauw, M Ruberg, et al.
Brain Research
|
October 8, 1993
Differential vulnerability to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine of dopaminergic and cholinergic neurons in the monkey mesopontine tegmentum
M T Herrero, E C Hirsch, F Javoy-Agid, et al.
Page
of 62